Turn this list into pipeline.
Medical Devices Companies in Cambridge: 28 Active Firms (2026)
Medical device companies design, manufacture and support regulated healthcare products for clinical use, across Cambridge and its surrounding area.
Buying centres cluster around clinical procurement, laboratory operations and life-sciences product teams rather than general corporate IT. Sales tend to be technical and evidence-led: buyers want product documentation, conformity paperwork, validation support, distribution assurance and post-market service as much as the device itself. The customer base is mostly B2B or institution-facing, with small specialist suppliers selling components, diagnostics, systems, procedure packs or support services into healthcare, laboratory and clinical channels. Engagements appear relatively narrow in scope, often attached to a particular device family, test workflow, manufacturing step or regulatory obligation, rather than broad outsourcing contracts.
Read more
Cambridge has 28 actively trading medical device firms in this list, which points to a compact local cohort rather than a broad manufacturing cluster. Reported headcount totals 145 employees, so the visible employment footprint is modest and consistent with specialist suppliers serving defined clinical or laboratory niches. None of the cohort reports turnover above £5M, and 5 firms were incorporated since 2022, suggesting a market weighted towards small operators, service-led device support and early commercial activity rather than revenue-scale manufacturers.
Medical devices placed on the Great Britain market sit under the MHRA, with GOV.UK guidance requiring registration before sale for devices including in vitro diagnostics, custom-made devices and systems or procedure packs. The main domestic framework is the Medical Devices Regulations 2002. Manufacturers need conformity assessment and product marking: UKCA is the Great Britain route, while transitional rules still allow some CE-marked devices until 30 June 2028 or 30 June 2030, depending on regime. Non-UK manufacturers must appoint a UK responsible person. Northern Ireland follows separate EU medical-device and in vitro diagnostic rules.
Cambridge appears to offer a research-adjacent supplier base rather than a dense device-manufacturing market. The cohort tends to sit close to laboratories, clinical users and life-sciences buyers, so demand may follow procurement cycles, evidence requirements and regulatory maintenance more than consumer healthcare trends. Scale-up scarcity suggests that many firms will remain specialist, with growth coming through repeat clinical channels, distributor relationships or product-line extensions. Compliance work is unlikely to become lighter; post-market surveillance, product marking and responsible-person obligations should keep regulatory capability central to how these firms win and retain customers.
28
Active firms
2026
0
Over £5M turnover
Cambridge-area firms
5
Incorporated since 2022
Cambridge-area firms
Key facts
17% of the cohort was incorporated since 2022 (5 firms), so a sizeable share is in its first few filing cycles.
Medical devices, including in vitro diagnostics, custom-made devices and systems or procedure packs, must be registered with the MHRA before being placed on the Great Britain market.
The Medical Devices Regulations 2002 are the main Great Britain framework, with UKCA marking as the domestic conformity route.
Transitional rules allow certain CE-marked devices onto the Great Britain market until 30 June 2028 or 30 June 2030, depending on device regime.
UK medical technology had 4,360 companies in 2023/2024, employing 196,000 people and generating £48.0 billion in turnover.
MedTech Europe puts Europe at 26.4% of the world market in 2024, behind the US at 46.4%.
Top Cambridge medical devices companies
TIDALSENSE LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops respiratory diagnostic and monitoring technology using AI and breath analysis. Its N‑Tidal platform combines sensors, connected devices and cloud software to detect and monitor conditions…
Serves healthcare providers and payers, NHS respiratory care pathways, clinicians working with COPD and asthma patients, pharmaceutical companies, and patients with respiratory conditions.
Financial Health
StableStable · Hiring · 20% CAGR over 2y
Location
Trajectory
2y · 2020–NowFinancial sub-scores
Computed from 2 filingsDevelops non-endoscopic diagnostic technologies for gastrointestinal diseases. Produces capsule sponge cell-collection devices and molecular tests, including EndoSign, used to detect and monitor…
Sells to healthcare providers and clinical researchers involved in gastrointestinal and oesophageal care, including community care settings focused on early detection and monitoring of Barrett’s…
Financial Health
StrongStrong · Hiring · 166% CAGR over 1y
Location
Exhalation Technology
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops breath‑analysis diagnostic technology for early detection of lung cancer. Its Inflammacheck device analyses biomarkers and breathing patterns in exhaled breath using sensors and AI to…
Sells to healthcare providers and health systems involved in lung cancer screening, including GP and outreach settings. Serves point-of-care and public health buyers seeking accessible screening for…
Financial Health
HealthyHealthy · Hiring · 10% CAGR over 2y
Location
Coherence Neuro Ltd
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops bioelectronic medical technology for cancer management, including an implantable brain–computer interface that monitors neural signals and delivers targeted stimulation. The platform…
Serves people with cancer, prospective clinical trial participants and their oncology care teams; also addresses researchers and partners in neurotechnology, neurobiology and cancer therapy.
Financial Health
StrongStrong · Hiring · 183% CAGR over 2y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops liquid biopsy technology for cancer research, including the VTX-1 system that isolates and collects circulating tumour cells from blood samples. Provides tools and services that enable…
Serves cancer researchers, oncology laboratories, academic medical centres, biotech and pharmaceutical teams working on liquid biopsy, precision oncology and anti-metastatic therapy development.
Financial Health
WeakWeak
Location
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops AI software that analyses H&E‑stained tissue images to infer molecular and multi‑omics biomarker profiles. The technology provides rapid tissue analysis for hospitals, laboratories, and…
Sells to hospitals, pathology labs and research organisations needing tissue-based molecular profiling, and serves drug development teams in biotech and pharma. Targets clinical diagnostics and…
Financial Health
WeakWeak · Hiring · 3% CAGR over 4y
Location
Aseptuva Ltd
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
StrongStrong
Location
Vagus Health Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed · 0% CAGR over 4y
Location
METICULY INNOVATIONS LTD
Trajectory
3y · 2022–NowFinancial Health
Insufficient historyInsufficient history
Location
Medcam Healthcare Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed · 0% CAGR over 4y
Location
Camstent
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops polymer surface coatings for medical devices designed to repel bacteria and reduce biofilm formation. Applies patented coatings to products such as Foley catheters and other tubes and…
Serves NHS hospitals and clinics, healthcare procurement teams and medical device manufacturers needing coated catheters and other consumable medical devices in the UK and Europe.
Financial Health
StrongStrong · Hiring · 11% CAGR over 4y
Location
CAMBRIDGE LIFE SCIENCES LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops, manufactures and supplies in vitro diagnostic assays and test kits for clinical laboratories, including therapeutic drug monitoring, autoimmune disease and gastrointestinal infection tests.…
Serves clinical laboratories, hospitals, endoscopy units and healthcare professionals worldwide, plus OEM partners and distributors seeking in vitro diagnostic products.
Financial Health
DistressedDistressed · -70% CAGR over 4y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and manufactures high‑sensitivity lateral flow diagnostic tests using eAMP DNA detection technology. Produces rapid point‑of‑care assays and research tools, including mycoplasma detection…
Serves healthcare providers, diagnostic manufacturers and public-health organisations needing rapid point-of-care tests, plus life-science researchers and cell-culture laboratories buying mycoplasma…
Financial Health
HealthyHealthy · Hiring · 5% CAGR over 4y
Location
Develops and manufactures magnetic surgical guidance and localisation technologies used in breast cancer surgery. Products include magnetic markers, tracers and detection systems that help surgeons…
Serves hospitals and breast cancer surgery teams worldwide, including surgeons and physicians seeking localization and staging technologies, with patient-facing resources for women undergoing breast…
Location
MURSLA LIMITED
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops AI-driven precision medicine diagnostics based on analysis of organ-specific extracellular vesicles isolated from blood. Produces blood tests including assays for early detection of liver…
Serves healthcare providers, hepatology and GI teams, and cancer surveillance programmes caring for high-risk cirrhosis patients, with an initial focus on US and European populations.
Financial Health
WeakWeak · -65% CAGR over 4y
Location
GSG Technology Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides engineering and technology consulting for product development, particularly in medical devices, molecular diagnostics, and scientific instruments. Services include concept design, analytical…
Serves B2B companies of all sizes in diagnostics, medical and surgical devices, scientific instrumentation, industrial control and custom manufacturing, typically founders and CTOs developing…
Financial Health
DistressedDistressed · 0% CAGR over 2y
Location
Cambridge Design
Trajectory
2y · 2020–NowProvides product design and development services for consumer, healthcare and industrial sectors, including user research, applied science, engineering, digital and data development, prototyping,…
Serves global brands and ambitious start-ups in consumer, healthcare and industrial markets, including FMCG, consumer technology, diagnostics, drug delivery, medical therapy and tobacco harm…
Financial Health
Insufficient historyInsufficient history
Location
Develops breath analysis technology and diagnostic tests that detect volatile organic compound (VOC) biomarkers. Provides breath sample collection devices, FAIMS-based analytical instruments, and…
Serves life sciences researchers, academic and clinical research teams, and healthcare or diagnostics organisations working on breath biomarker studies in cancer, respiratory, gastrointestinal,…
Location
Team Medical
Develops medical device technologies and prototypes, and provides consulting for product design, R&D, engineering, and laboratory testing. Also offers technology assessment, manufacturing process…
Sells to medical device and healthcare product companies seeking to expand product lines, plus legal teams needing expert witness support in medical device IP and business disputes. Serves firms…
Location
POLYMER BIONICS LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDevelops flexible bioelectronic technologies and polymer‑based medical devices for healthcare applications, focusing on electronic systems designed to interface with biological tissue for wearable or…
Financial Health
StrongStrong
Location
VERINNOGEN LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
StrongStrong
Location
OUTSIDE IN (CAMBRIDGE) LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · -67% CAGR over 4y
Location
ROLLZ MOBILITY UK LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable · -68% CAGR over 4y
Location
HEARTFELT MEDICAL LTD
Trajectory
3y · 2023–NowFinancial Health
Insufficient historyInsufficient history
Location
CN RESPIRATORY SOLUTIONS LIMITED
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
Provides product and technology consultancy, designing and developing advanced hardware and software systems including medical devices, diagnostics, AI‑enabled cyber‑physical systems, defence…
Sells to businesses and government organisations developing complex technology products, especially in defence, energy, industrials, diagnostics, life sciences, medical devices, satellite and space.…
Location
NPZ Technology Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
C Chambers Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies laboratory equipment for microbiology and cell culture, including anaerobic, hypoxic and microaerobic workstations, GMP isolators, and modified‑atmosphere chambers. Also distributes lab…
Sells to B2B and public-sector laboratory teams in microbiology, cell culture and tissue engineering, including pharmaceutical, clinical diagnostics, food testing, research and academic organisations.
Financial Health
HealthyHealthy · 0% CAGR over 4y
Location
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops single‑molecule imaging technology including benchtop instruments, consumables and analysis software that use advanced optics and machine learning to detect, count and quantify DNA, proteins…
Sells to biomedical research and diagnostic users, including pharma and biotech teams involved in drug development, antibody discovery, vaccine development and molecular analysis, as well as…
Financial Health
StrongStrong · Hiring · 93% CAGR over 4y
Location
PAEDIATRIC HEALTHTECH LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and supplies clinical diagnostic products and services, including laboratory analysers, reagents, quality control and external quality assessment schemes. Provides pathology testing,…
Serves clinical laboratories, healthcare providers, biopharma companies, employers needing workplace testing, food industry organisations, veterinary and forensic/toxicology labs, and consumers…
Financial Health
HealthyHealthy · 0% CAGR over 2y
Location
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsDevelops cell analysis technology that characterises cells using 3D fluorescence and label‑free imaging data, providing insights for drug discovery research and biotechnology cell manufacturing…
Sells to B2B life sciences customers, including biotech and pharmaceutical R&D teams in drug discovery and organisations involved in cell manufacturing.
Financial Health
WeakWeak · Hiring · 46% CAGR over 2y
Location
Cellular Highways
Supplies laboratory reagents, cell culture media, antibodies, assay kits, instruments, and related tools for stem cell and immunology research. Also provides contract research, cell characterization,…
Serves life science researchers, academic and clinical laboratories, biopharmaceutical companies, cell therapy developers, diagnostics/OEM partners, and contract research customers in stem cell,…
Location
Unlock all 28 leads
Showing 33 of 28 — +0 more with verified decision-maker contacts, live data, and CRM sync.
How Cambridge medical devices companies work and how to sell to them
What they do
Revenue usually comes from a mix of device sales, consumables, support contracts, distributor margins and project work around design, validation or regulatory documentation. Cambridge firms in this niche are often closer to laboratories and clinical teams than to volume consumer channels, so pricing tends to follow a technical engagement: per unit, per kit, per test, per service visit or per engineering project. Some sell hardware with recurring consumables or maintenance; others earn fees for procedure packs, diagnostic workflows, specialist components or after-sales support. The commercial shape is therefore narrower than general health technology, with revenue linked to defined use cases, evidence packs and repeat purchasing by professional buyers.
Who they sell to
Most sell to hospital procurement teams, clinical departments, diagnostic laboratories, life-sciences product groups, distributors and specialist service providers. The practical decision-maker is often a clinician, lab manager, quality or regulatory affairs lead, operations director or procurement manager, with finance joining once repeat supply or framework-style purchasing is in view. Contract size is usually tied to device risk, validation effort and service burden rather than a simple seat count. Sales cycles tend to be shortest for standard consumables and replacement parts, and longer where buyers need clinical input, supplier qualification, conformity evidence, change-control review or distributor approval before purchase.
What they buy
Medical device companies tend to buy tools and services that protect traceability, documentation quality and route-to-market assurance. Common spend areas include quality management software, document control, complaint handling, post-market surveillance, regulatory affairs support, clinical evaluation writing, test-house services, calibration, sterilisation, inventory control and supplier qualification. Firms with manufacturing or distribution activity may also need ERP, warehouse systems, CRM, field-service management, cybersecurity, insurance, legal advice and accounting support. Recruitment demand often sits around quality assurance, regulatory affairs, product engineering, validation, clinical application support and commercial roles that can sell into healthcare or laboratory channels without over-promising evidence.
Why and how to sell to them
Buying intent often appears when a firm moves from prototype into repeat supply, adds a new device family, appoints a quality or regulatory lead, signs a distributor, prepares for MHRA registration or works through UKCA and CE-marking changes. Audit findings, customer complaints, product changes and overseas market entry can also create budget for external systems or services. Outbound messages should be specific to the buyer’s obligation: fewer uncontrolled documents for quality teams, clearer evidence for procurement, faster complaint triage for service teams, or cleaner supplier traceability for operations. Generic productivity claims tend to land poorly unless tied to compliance, validation or release risk.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Cambridge
Related directories
Frequently asked questions
How many medical devices companies are there in the Cambridge?↓
What counts as a medical devices company in this list?↓
Which are the largest medical devices companies in the Cambridge?↓
What do medical devices companies in the Cambridge actually do?↓
How does Cambridge medical devices compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical medical devices companies in the Cambridge?↓
Are these mostly new or established medical devices companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 28 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.